A- A A+ Search USA USA MammaPrint in Australia MammaPrint in Germany MammaPrint in Italy MammaPrint in Nederland MammaPrint in New Zealand MammaPrint in United Kingdom Publications Ordering Client Login Contact Us Physician Education Main menu Skip to primary content Skip to secondary content About Us Our Science Physicians Managed Care Patients Investors & Press ABC News Half of early stage breast cancer patients may be able to avoid chemotherapy. Agendia Test for Molecular Subtyping of Breast Cancer Is a Better Guide to Pre-Surgical Treatment, Study Finds READ MORE Agendia Announces Study Showing Molecular Subtyping Can Improve Breast Cancer Treatment READ MORE Careers Terms and Service Privacy Policy Notices Site Map © Copyright Agendia, Inc.